Spinocerebellar Ataxia Panel (SCA1,2,3,6, and 7)
- GTR Test IDHelpEach Test is a specific, orderable test from a particular laboratory, and is assigned a unique GTR accession number. The format is GTR00000001.1, with a leading prefix 'GTR' followed by 8 digits, a period, then 1 or more digits representing the version. When a laboratory updates a registered test, a new version number is assigned.: GTR000529286.3
- Last updated: 2021-10-14
- Annual Review past due read more
- Test version history
Clinical testHelpIn the U.S., clinical tests must be performed under CLIA certification. When a lab uses the same methods for a test in both clinical and research settings, the test appears as two separate GTR records. for Hereditary ataxia
Offered by Center for Genetics at Saint Francis
Overview
Test name
HelpThe name the laboratory assigns the test. Used as the default title of the page specific to the test.Spinocerebellar Ataxia Panel (SCA1,2,3,6, and 7) (SCA Panel)
This is a clinical test intended for HelpPurposes or indications for the test. Lab-provided.: Diagnosis, Pre-symptomatic
Click Indication tab for more information.
Obtain specific specimen information from website. Submit a test requisition form with billing information when submitting a specimen for testing.
Order URL HelpLink to the laboratory webpage with information about how to order this test. Please note that clicking on this link will open a new tab in your internet browser.: http://www.saintfrancis.com/genetics/Pages/Test-Ordering.aspx
Specimen source
Methodology
HelpThe assay's major method category (biochemical, cytogenetic or molecular genetics); method category (i.e. enzyme assay, chromosome breakage studies, targeted mutation analysis); methodology (i.e. the name of the method used) and instruments used when performing this test.- Molecular Genetics
- TTargeted variant analysis
- Trinucleotide repeat by PCR or Southern Blot
- Applied Biosystems 3130 Capillary Sequencing Instrument
Establish or confirm diagnosis
- Hereditary Ataxia Overview - PubMed ID: 20301317
- https://www.ncbi.nlm.nih.gov/books/NBK1138
Clinical validity
HelpHow consistently and accurately the test detects or predicts the intermediate or final outcomes of interest. Lab-provided.Clinical Sensitivity is 99%. Over 95% of ataxia conditions (by incidence) are encompassed by this panel.
Citations
Not provided
Test services
HelpLaboratory's order or catalog code for the test (used in the order requisition form).- Clinical Testing/Confirmation of Mutations Identified Previously
- Custom mutation-specific/Carrier testing
IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.